The extensive discussion between the FDA’s advisory committee, company representatives and other interested parties could serve as a cautionary tale to developers of future gene therapies.
Opinion: Sarepta Enters Uncharted Territory with Adcomm Approval Read More »
Si estas en búsqueda de un préstamo, una excelente alternativa es comparar productos. De esa forma, podrás encontrar la oferta de financiación con las mejores condiciones del mercado, aquellas que se adaptan a tus necesidades. Aprende aquí cómo com …
En este Short conoceremos un animal capaz de generar sustancias que parecían exclusivas de las plantas. …
Animal cuyo cuerpo sin boca ni tripa fabrica sustancias vegetales Read More »
En este Short examinamos la posibilidad de que dormir mal pueda ocasionar graves problemas futuros de audición. …
¿Pérdida de audición debido a una mala calidad del sueño? Read More »
A mucha gente le resulta familiar la Tierra vista desde su órbita o incluso desde la Luna. Pero esta foto, en la cual la Tierra es el puntito luminoso hacia el centro de la imagen, fue tomada desde mucho más lejos. Este panorama cósmico fue captado por la sonda espacial Cassini …
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) announced the Company will present data from RUBY-1, a phase 1 study of povetacicept in healthy adult volunteers, at multiple upcoming scientific congresses, including participation in a poster tour at the European Congress of Rheumatology (EULAR) and an oral presentation at the European Hematology Association (EHA).
The Rochester, Minnesota-based academic medical system reported increased admissions and revenue in the first quarter. Operating expenses also grew, largely due to salary and benefit costs.
Mayo Clinic grew profits in Q1, despite rising expenses Read More »
Luxury vacations and tickets to Broadway shows were used by the Minnesota-based ophthalmologic supply company to induce surgeons to use its products, a federal court ruled.
Political will seems to be rising to address drivers of rising medical costs and poor access to care, according to lawmaker comments on the Hill.
What three key congressional hearings this week mean for the industry Read More »
Boston Scientific has used “tuck-in” acquisitions to boost growth in the past. Some analysts say it should stay the course amid a report the company may make a bid.
A Boston Scientific purchase of Shockwave could be transformative — but at what price? Read More »
